Researchers have discovered that prostate cancer depends on two key enzymes, PDIA1 and PDIA5, to survive and resist therapy.

Two U.S. Food and Drug Administration (FDA)-approved drugs for treating prostate cancer may also be effective against acute ...

A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...

New hope for advanced prostate cancer patients, with promising new drug combo that targets genes, such as BRCA1, BRCA2, CHEK2 ...

At 31, Rohan should have been planning his next trek in Himachal, not learning how to pronounce adenocarcinoma. Fit, cheerful ...

Sansum Clinic and Ridley-Tree Cancer Center will share a panel discussion that was presented on prostate health. To view the video presentation, click ...

At 31, Rohan should have been planning his next trek in Himachal, not learning how to pronounce adenocarcinoma. Fit, cheerful, and the office’s go-to for wellne ...

BALTIMORE, Nov. 13, 2025 (GLOBAL NEWSWIRE) — The Urology Care Foundation (UCF), the official foundation of the American Urological Association (AUA), and the Prostate Cancer Foundation (PCF) today ...

I’m a 64-year-old man who was recently diagnosed with an enlarged prostate after experiencing issues with frequent urination, ...

SCIMITAR is the first phase 2 trial testing the efficacy of stereotactic body radiation therapy (SBRT) targeting the prostate fossa after radical prostatectomy.

KUALA LUMPUR: The public has been encouraged to report network coverage issues in their respective areas through the MCMC Nexus mobile application. Deputy Communications Minister Teo Nie Ching said ...